Home/Pipeline/TCM Product Portfolio

TCM Product Portfolio

Cardiovascular, Digestive, Metabolic Disorders

Marketed / NDACommercial

Key Facts

Indication
Cardiovascular, Digestive, Metabolic Disorders
Phase
Marketed / NDA
Status
Commercial
Company

About China SXT Pharmaceuticals

China SXT Pharmaceuticals (NASDAQ: SXTC) is a China-based specialty pharmaceutical company with a dual-mission to modernize Traditional Chinese Medicine (TCM) and produce generic drugs. The company has established an integrated operational model, managing R&D, manufacturing, and commercialization in-house, primarily targeting high-prevalence conditions in its domestic market. Its strategy hinges on capitalizing on government support for TCM integration into the healthcare system and the ongoing demand for affordable generic pharmaceuticals, though it faces significant execution and competitive risks.

View full company profile